Episode
Multiple Myeloma — Fifth Annual National General Medical Oncology Summit
- Podcast
- Hematologic Oncology Update
- Published
- Jun 18, 2026
- Duration seconds
- 2825
- Processing state
not_requested- Canonical source
- https://hematologic-oncology.captivate.fm/episode/6009-gmo26-mm
Actions
POST https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/multiple-myeloma-fifth-annual-national-general-medical-oncology-summit/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/hematologic-oncology-update-916423/multiple-myeloma-fifth-annual-national-general-medical-oncology-summit.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Featuring perspectives from Dr Hans Lee and Dr Noopur Raje, including the following topics: Introduction (0:00) Integrating Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies into the Management of Relapsed/Refractory Multiple Myeloma (R/R MM) — Dr Raje (4:30) Antibody-Drug Conjugates and Other Emerging Therapies for R/R MM — Dr Lee (28:33) CME information and select publications